Compugen Ltd (NASDAQ: CGEN) is 48.99% higher on its value in year-to-date trading and has touched a low of $0.53 and a high of $2.85 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CGEN stock was last observed hovering at around $2.64 in the last trading session, with the day’s gains setting it 0.31%.
Currently trading at $2.95, the stock is 25.21% and 39.51% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.7 million and changing 11.74% at the moment leaves the stock 135.74% off its SMA200. CGEN registered 270.32% gain for a year compared to 6-month gain of 158.77%. The firm has a 50-day simple moving average (SMA 50) of $23.59 and a 200-day simple moving average (SMA200) of -$5.40.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 21.90% loss in the last 1 month and extending the period to 3 months gives it a 345.15%, and is 15.23% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.96% over the week and 8.01% over the month.
Compugen Ltd (CGEN) has around 69 employees, a market worth around $260.57M and $7.50M in sales. Profit margin for the company is -420.79%. Distance from 52-week low is 456.60% and 3.51% from its 52-week high. The company has generated returns on investments over the last 12 months (-58.39%).
Compugen Ltd quarterly earnings per share for the current quarter are estimated at $0.22 with sales reaching $20M over the same period.The EPS is expected to grow by 50.43% this year, but quarterly earnings will post 200.00% year-over-year. Quarterly sales are estimated to grow 166.70% in year-over-year returns.
Compugen Ltd (CGEN) Top Institutional Holders
86 institutions hold shares in Compugen Ltd (CGEN), with institutional investors hold 13.95% of the company’s shares. The shares outstanding are 86.62M, and float is at 83.51M with Short Float at 2.42%. Institutions hold 13.94% of the Float.
The top institutional shareholder in the company is Taylor Frigon Capital Management LLC with over 1.99 million shares valued at $2.27 million. The investor’s holdings represent 2.26% of the CGEN Shares outstanding. As of Jun 29, 2023, the second largest holder is Rock Springs Capital Management, LP with 1.29 million shares valued at $1.47 million to account for 1.46% of the shares outstanding. The other top investors are Sphera Funds Management Ltd. which holds 1.23 million shares representing 1.39% and valued at over $1.4 million, while Renaissance Technologies, LLC holds 1.18% of the shares totaling 1.04 million with a market value of $1.18 million.
Compugen Ltd (CGEN): Who are the competitors?
The company’s main competitors (and peers) include Teva Pharmaceutical Industries Ltd. ADR (TEVA) that is trading 35.62% up over the past 12 months. Evogene Ltd. (EVGN) that is 28.84% higher over the same period.
